Stock Market Today, Oct. 26: AI Optimism Lifts Nasdaq as Tech Stocks Rebound

The S&P 500 gained 0.70% to 7,677 and the Nasdaq rose 0.82% to 26,169 as Anthropic’s Nasdaq IPO filing and revenue growth figures revived AI optimism; the Dow added 0.28% to 52,362. Tesla rose more than 5% after Barclays upgraded it to Overweight and raised its price target from $370 to $450, while Meta fell 2% after disclosing plans to raise up to $95 billion for AI infrastructure. Investors are watching this week’s Microsoft earnings and the upcoming Federal Reserve rate decision; the 10-year Treasury yield rose 0.04% to 5%.

Analysis

The key distinction is between AI capex beneficiaries and the companies funding that capex. If infrastructure spending converts into optical-network orders, Lumentum could capture near-term demand while spending-heavy platforms face margin and cash-flow scrutiny—though one bullish initiation is not evidence of order growth. Microsoft’s results are the next test: stronger cloud demand and monetization would support the spending cycle; rising investment without corresponding revenue traction would pressure the whole trade. A 5% 10-year yield raises the hurdle for long-duration growth and makes this week’s Fed signal relevant to multiples, not just sentiment.

The Anthropic filing may broaden AI exposure, but IPO enthusiasm is not yet evidence of durable sector economics. Watch for disclosed customer concentration, gross margins, cash burn, and use of proceeds before extrapolating its growth to public peers. Tesla’s rally tied partly to prospective robotaxi and SpaceX-related optionality is vulnerable if execution or any claimed commercial linkage remains unverified. Surgery Partners’ sharp repricing is now chiefly deal-risk: absent terms, premium and financing details, upside is hard to underwrite. Petrobras faces a policy-risk repricing; distinguish campaign signals from implemented changes before extrapolating across Brazilian energy. Near term, earnings/Fed can reverse the risk-on move; over 6–18 months, returns hinge on AI capex monetization and rates.

Key Decisions for Investors

• Avoid chasing Lumentum after the gap. Consider a small, defined-risk long only if subsequent commentary or filings confirm AI-related order conversion; falsify on weaker forward demand or guidance. Verify customer concentration and backlog before sizing.
• For a relative-value expression, consider a modest long Lumentum / short Meta pair: it isolates the possibility that infrastructure suppliers capture spend while platforms absorb funding costs. Keep sizing conservative; reduce or exit if Microsoft’s results show monetization accelerating enough to validate platform spending, or if Lumentum fails to show demand conversion.
• Wait for Microsoft earnings and the Fed decision before adding broad Nasdaq exposure. A cloud-growth beat accompanied by credible returns on AI investment supports risk-on; capex acceleration without monetization, or a further rise in long yields, argues to hedge with less rate-sensitive exposure.
• Do not chase Surgery Partners or Tesla solely on the reported catalysts. For Surgery Partners, verify transaction terms and closing conditions; for Tesla, require operating evidence for robotaxi economics and any SpaceX-linked benefit. Reassess Petrobras only as policy proposals become concrete; monitor regulatory decisions and the company’s capital-allocation signals.